The FDA has approved and granted emergency use authorization for updated mRNA COVID-19 vaccines for the 2024-2025 formula, targeting the Omicron variant KP.2 strain of SARS-CoV-2. This update aims to... Read More
The FDA has approved and granted emergency use authorization for updated mRNA COVID-19 vaccines for the 2024-2025 formula, targeting the Omicron variant KP.2 strain of SARS-CoV-2. This update aims to... Read More